Combining Two Anticancer Drugs Improves Remission Rates In Patients With Primary Central Nervous System Lymphoma
Links shared publicly online about this topic.
- 1,731total visits
Combining Two Anticancer Drugs Improves Remission Rates In Patients With Primary Central Nervous System Lymphoma
Combining cytarabine with conventional monochemotherapy (high-dose methotrexate) improves remission rates in patients with primary central nervous system lymphoma. (primary cns lymphoma). the find
View full resource at medicalnewstoday.com
Tags: Nervous System, Cancer, Lymphoma, Rheumatoid Arthritis Medication, Drug, Rheumatrex, Trexall, Folex PFS
Most Recently Shared on September 22, 2009 at 11:12 am By:
Combining Two Anticancer Drugs Improves Remission Rates In Patients With Primary Central Nervous System Lymphoma.. http://bit.ly/14PWsX
Advertisement
